Regeneron CEO on 23andMe Acquisition, US-China Trade Deal, and Jimmy Buffett's Estate

Regeneron's Bid for 23andMe

• 💰 Regeneron CEO Dr. Len Schleifer discusses the company's $256 million bid to acquire the bankrupt DNA testing company 23andMe.
• ⚠️ Concerns have been raised by Congressman James Comr regarding Regeneron's alleged ties to the Chinese Communist Party, which Schleifer categorically denies, stating they have no direct business in China.
• 🧬 Schleifer emphasizes Regeneron's commitment to using genetic data for world-class research to develop new drug therapies, while respecting individual privacy through de-identification.
• 💡 He highlights the potential of genetics to predict drug efficacy, citing Dupixent's success in treating various allergic diseases as an example.
• 👂 A compelling example of Regeneron's work includes a gene therapy that restored hearing to a child born profoundly deaf.

US-China Trade Relations

• 🤝 Officials from the US and China have agreed in principle to a framework for a trade deal following high-level talks in London.
• 📈 The deal aims to remove restrictions on certain Chinese exports, including rare earth minerals, and some US export restrictions on high-tech goods.
• ❓ Details remain scarce, and the deal awaits final approval from both presidents, with ongoing debates about balancing national security concerns with trade.

Elon Musk's Apology and Tesla

• ✍️ Elon Musk expressed regret on X for his public feud with President Trump, stating some of his posts